Clinical Trial Update: Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the combination of fludarabine, carboplatin, and topotecan in relapsed/refractory acute leukemia or advanced myelodysplastic s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Fludarabine (Fludarabine)
• Topotecan (topotecan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED